Usana Health Sciences Inc [NYSE: USNA] plunged by -$0.64 during the normal trading session on while it closed the day at $29.42.
Usana Health Sciences Inc stock has also loss -2.81% of its value over the past 7 days. However, USNA stock has declined by -10.00% in the 3 months of the year. Over the past six months meanwhile, it has lost -24.64% and lost -18.03% year-on date.
The market cap for USNA stock reached $547.89 million, with 18.79 million shares outstanding and 11.14 million shares in the current float. Compared to the average trading volume of 239.71K shares, USNA reached a trading volume of 125464 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Usana Health Sciences Inc [USNA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for USNA shares is $61.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on USNA stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Sidoti have made an estimate for Usana Health Sciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 23, 2023. While these analysts kept the previous recommendation, Jefferies dropped their target price from $78 to $53. The new note on the price target was released on July 07, 2022, representing the official price target for Usana Health Sciences Inc stock. Previously, the target price had yet another raise to $86, while DA Davidson analysts kept a Neutral rating on USNA stock.
The Average True Range (ATR) for Usana Health Sciences Inc is set at 1.00, with the Price to Sales ratio for USNA stock in the period of the last 12 months amounting to 0.63. The Price to Book ratio for the last quarter was 1.04, with the Price to Cash per share for the same quarter was set at 9.64. Price to Free Cash Flow for USNA in the course of the last twelve months was 11.15 with Quick ratio for the last quarter at 1.51.
USNA stock trade performance evaluation
Usana Health Sciences Inc [USNA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.81. With this latest performance, USNA shares gained by 8.56% in over the last four-week period, additionally sinking by -24.64% over the last 6 months – not to mention a drop of -40.89% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for USNA stock in for the last two-week period is set at 55.87, with the RSI for the last a single of trading hit 53.28, and the three-weeks RSI is set at 54.57 for Usana Health Sciences Inc [USNA]. The present Moving Average for the last 50 days of trading for this stock 27.34, while it was recorded at 29.87 for the last single week of trading, and 34.05 for the last 200 days.
Usana Health Sciences Inc [USNA]: An insightful look at the core fundamentals
Usana Health Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.51 and a Current Ratio set at 2.05.
Usana Health Sciences Inc [USNA]: Institutional Ownership
There are presently around $58.66%, or 101.42%% of USNA stock, in the hands of institutional investors. The top three institutional holders of USNA stocks are: BLACKROCK INC. with ownership of 1.77 million shares, which is approximately 9.2323%. VANGUARD GROUP INC, holding 1.57 million shares of the stock with an approximate value of $$71.25 million in USNA stocks shares; and VANGUARD GROUP INC, currently with $$53.35 million in USNA stock with ownership which is approximately 6.1498%.
